0 Comments
0 Shares
90 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Global Cancer Drugs Market Set for Exponential Growth, Targeting USD 1.81 Billion by 2032 as Immunotherapies Reshape Oncology LandscapeMarket Projected to Accelerate at 4.71% CAGR Driven by Precision Medicine Adoption and the Rise of Novel Cell and Gene Therapies The global Cancer Drugs Market, highlighting a profound shift toward curative and highly targeted therapeutic modalities. The market, valued at a substantial USD 1.19 Billion in 2023, is projected to reach USD 1.81 Billion by 2032, recording a robust Compound Annual...0 Comments 0 Shares 2K Views 0 Reviews
-
High Potency API Market: Increasing Investments in Oncology Drugs and Specialized ManufacturingAccording to a new report published by Introspective Market Research, titled, High Potency Active Pharmaceutical Ingredients Market by Type, Synthesis, and Application, The Global High Potency Active Pharmaceutical Ingredients Market Size Was Valued at USD 26.42 Billion in 2023 and is Projected to Reach USD 66.71 Billion by 2032, Growing at a CAGR of 10.84%. 2. Introduction / Market...0 Comments 0 Shares 2K Views 0 Reviews
-
Oncology Drugs Market Outlook 2026–2034 Innovations Driving the Future of Cancer TreatmentThe Oncology Drugs Market is experiencing remarkable growth, driven by the increasing global burden of cancer, continuous advancements in targeted therapies, and expanding adoption of personalized medicine. As healthcare systems worldwide focus on improving cancer survival rates and treatment outcomes, oncology drugs are becoming a cornerstone of modern healthcare and pharmaceutical...0 Comments 0 Shares 76 Views 0 Reviews
-
Oncology Drugs Market Trends, Growth, and Breakthrough TherapiesOncology Drugs Market Report: Rising Demand for Precision Medicine and Immunotherapies The oncology drugs market is anticipated to experience substantial growth from 2025 to 2033, increase in the adoption of automation technologies in the food and beverage industry being a key factor propelling this growth. With an estimated valuation of approximately USD 253.6 billion in...0 Comments 0 Shares 471 Views 0 Reviews
-
Oncology Drugs Market Trends, Growth, and Breakthrough TherapiesOncology Drugs Market Report: Rising Demand for Precision Medicine and Immunotherapies The oncology drugs market is anticipated to experience substantial growth from 2025 to 2033, increase in the adoption of automation technologies in the food and beverage industry being a key factor propelling this growth. With an estimated valuation of approximately USD 253.6 billion in...0 Comments 0 Shares 499 Views 0 Reviews
-
The Generic Oncology Drugs Market is Forecasted to Reach US$ 42.43 Billion by 2031 Amid Growing Generic Drug AdoptionThe global Generic Oncology Drugs Market is witnessing remarkable growth due to the increasing prevalence of cancer worldwide and the rising demand for affordable treatment options. Healthcare systems across developed and emerging economies are actively adopting generic oncology drugs to reduce the financial burden associated with cancer therapies. The growing number of patent expirations for...0 Comments 0 Shares 228 Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 8K Views 0 Reviews
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Comments 0 Shares 3K Views 0 Reviews
-
Anti-Radiation Drugs Market Size, Share, and Strategic OutlookAdvancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Comments 0 Shares 6K Views 0 Reviews
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Comments 0 Shares 2K Views 0 Reviews
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 4K Views 0 Reviews1
-
Estramustine Phosphate Sodium Market Dynamics and Opportunities 2031Estramustine Phosphate Sodium is an oncology drug primarily indicated for the treatment of metastatic or advanced prostate cancer. It integrates estrogenic components with cytotoxic activity to inhibit cancer cell proliferation. By targeting tumor cell division pathways, it supports disease control in patients requiring specialized therapeutic interventions. Market Overview The Estramustine...0 Comments 0 Shares 2K Views 0 Reviews
-
Geographic Share Dynamics and Strategic Growth in Adult Malignant Glioma Therapeutics Market: Analysis and Forecast to 2031The global healthcare industry is witnessing significant transformation in oncology, particularly in the treatment of aggressive brain tumors such as malignant gliomas in adults. Increasing prevalence of glioblastoma, coupled with advancements in targeted therapies, immunotherapy, and precision medicine, is reshaping treatment approaches and improving patient outcomes. Rising investments in...0 Comments 0 Shares 1K Views 0 Reviews
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comments 0 Shares 3K Views 0 Reviews
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 1K Views 0 Reviews1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Comments 0 Shares 1K Views 0 Reviews1
-
Global High Potent Pharmaceuticals Product Market Outlook: Growth Trends, Forecasts & Strategic AnalysisHigh Potent Pharmaceutical Products refer to drugs with extremely high pharmacological potency that can affect the body even at small concentrations. Because of their strong biological effects, they must be manufactured under controlled environments. These products are widely used in cancer treatment and hormone-based therapies. High Potent Pharmaceuticals Product Market Analysis and...0 Comments 0 Shares 2K Views 0 Reviews
-
In-Depth Growth Drivers and Strategic Trends in the Breast Cancer Therapeutics Market Developments and Forecast by 2030The Breast Cancer Therapeutics Market is witnessing substantial growth as healthcare systems worldwide intensify efforts to combat one of the most prevalent cancers affecting women. Driven by rising incidence rates, improved diagnostic capabilities, and a strong pipeline of innovative therapies, the market is positioned for remarkable expansion over the next decade. According to industry...0 Comments 0 Shares 1K Views 0 Reviews
More Results